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General information. All reactions involving oxygen or moisture sensitive compounds were 
carried out under a dry nitrogen atmosphere. THF was distilled from sodium and CH2Cl2 was 
distilled from CaH2. Column chromatography was performed using Acros silica gel (0.030-0.075 
mm). Petroleum ether (PE, 60/80) used for chromatography was distilled prior to use. TLC 
analyses were performed on Merck F-254 silica gel plates. IR spectra were measured using a 
Bruker IFS 28 FT-spectrophotometer and wavelengths (ν) are reported in cm-1. 1H NMR spectra 
were recorded on a Bruker ARX 400 (400 MHz) or Varian Inova (500 MHz) spectrometer. The 
latter machines were also used for 13C NMR spectra (50, 100 and 125 MHz, respectively). Unless 
otherwise indicated, CDCl3 was used as the solvent. Chemical shifts are given in ppm (δ) relative 
to an internal standard of chloroform (7.26 ppm for 1H-NMR and 77.0 for 13C-NMR). 
 
 
 (S)-3,3'-Bis-(tert-butyl-dimethyl-silanyloxy)-9H,9'H-[4,4']bicarbazolyl. A solution of 
BICOL1 (0.50 g, 1.4 mmol), MeCN (14 cm3), imidazole (0.33 g, 4.8 
mmol) and TBDMSCl (0.54 g, 3.6 mmol) in MeCN (15 cm3) was heated 
at 65 ºC for 4 h. After cooling to room temperature the reaction mixture 
was quenched with water, EtOAc and NaHSO4. The product was 
extracted with EtOAc and the water layer was extracted two times with 
EtOAc. The organic layers were washed with brine, dried over MgSO4 
and concentrated in vacuo. Purification by column chromatography 
(PE/EtOAc = 60/40) afforded the product (0.69 g, 85%) as an off-white foam. Rf = 0.57. 1H NMR 
(CDCl3): δ -0.20 (s, 6 H), -0.01 (s, 6 H), 0.5 (s, 18 H), 6.69 (t, J = 7.2 Hz, 2 H), 6.91 (d, J = 8.0 
Hz, 2 H), 7.01 (d, J = 8.8 Hz, 2 H), 7.18 (t, J = 7.2 Hz, 2 H), 7.26 (d, J = 7.2 Hz, 2 H), 7.37 (d, J 
= 8.8 Hz, 2 H), 7.93 (s, 2 H); 13C NMR (CDCl3): δ 146.8, 140.2, 134.5, 124.9, 123.9, 123.5, 
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122.3, 121.7, 118.4, 117.4, 109.6, 109.5, 25.0, 17.5, -4.7; IR (NaCl, cm-1): 3422, 2954, 2929, 
2886, 2856, 1507, 1478, 1435, 1287, 1265, 952, 832.  
Bromo- acetic acid 2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethyl ester. To a stirred 
solution of bromoacetic acid (2.58 g, 18.5 mmol) and thionyl chloride (1.90 
cm3, 22.2 mmol) in dichloromethane (185 cm3), tetraethylene glycol 
monomethylether (5.00 g, 24.0 mmol) was added dropwise and the resulting 
reaction mixture was stirred at room temperature overnight. The solvent was removed under 
reduced pressure and the product was purified using column chromatography (PE/EtOAc = 
25/75) yielding a slightly yellow liquid (4.98 g, 15.6 mmol, 82 %). Rf-value: 0.15 (PE/EtOAc, 
50/50); 1H NMR (CDCl3): δ 4.31 (t, J = 4.7 Hz, 2H), 3.85 (s, 2H), 3.71 (t, J = 4.8 Hz, 2H), 3.64 
(m, 10H), 3.53 (t, J = 4.9Hz, 2H), 3.36 (s, 3H); 13C NMR (CDCl3): δ  166.95,  71.64, 70.35, 
70.32, 70.31, 70.28, 70.21, 68.45, 65.03, 58.72, 25.62; IR (NaCl, cm-1): 1736.5.    
 
 (S)-N-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethyl ester-3,3'-Bis-(tert-butyl-dimethyl-
silanyloxy)-9H,9’H-[4,4’]Bicarbazole. To a solution of the starting 
biscarbazole (722 mg, 1.22 mmol) in THF (12.2 cm3) and DMF (12.2 
cm3), KHMDS (6.0 cm3 of a 0,5 M solution in toluene, 3.0 mmol) was 
added dropwise at 0 ºC and the solution was stirred at room temperature 
for 1 h. After this time the bromoalkyl ester (1.90 g, 4.88 mmol) was 
added dropwise and the resulting reaction mixture was stirred at room 
temperature for 4 h. After this time a two-phase separation was carried 
out using EtOAc, water, brine and NH4Cl. The organic phase was washed 
four times with water and brine, dried over MgSO4 and evaporated under 
reduced pressure. The product was further purified using column 
chromatography on silica gel (gradient PE/EtOAc = 4/1 to EtOAc/MeOH 
= 95/5) yielding a brown oil (260 mg, 20 %). Rf-value: 0.24 (EtOAc); 1H NMR (CDCl3): δ 7.26 
(d, J = 4.0 Hz, 2H), 7.13 (d, J = 3.6 Hz, 2H), 7.05 (d, J = 8.4 Hz, 2H), 6.80 (d, J = 8.0 Hz, 2H), 
6.64 (m, 2H), 5.01 (s, 4H), 4.24 (m, 4H), 3.58 (m, 24H), 3.47 (m, 4H), 3.29 (d, J = 6.8 Hz, 6H), 
0.38 (s, 18H), -0.11 (s, 6H), -0.31 (s, 6H); 13C NMR (CDCl3): δ 168.63, 147.16,  141.10, 135.70, 
125.20, 123.64, 123.24, 122.52, 121.90, 118.76, 117.41, 107.47, 107.43, 71.89, 70.62, 70.58, 
70.54, 70.49, 68.82, 68.71, 64.43, 58.98, 44.75, 25.06, 17.56, -4.60; IR (NaCl, cm-1):  1754; 




 (S)-N-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethyl ester- 9H,9’H-[4,4’]Bicarbazole-3,3’-
diol. To a solution of the TBDMS-protected biscarbazole (260 mg, 0.23 
mmol) in THF (5.0 cm3), TBAF (0.483 cm3 of a 1 M solution in THF, 0.47 
mmol) was added and the resulting reaction mixture was stirred at room 
temperature for 10 minutes. After this time a two-phase separation was 
carried out using EtOAc, water, brine and NaHSO3 (0.5 M). The organic 
phase was washed one time with water and brine, dried over MgSO4 and 
evaporated under reduced pressure. The product was further purified using 
column chromatography  (PE/EtOAc = 0/1) yielding a light brown oil (169 
mg, 85%). Rf-value: 0.06 (PE:EtOAc, 0:1); 1H NMR (CDCl3): δ = 7.40 (d, 
J = 8.8 Hz, 2H), 7.30 (d, J = 8.7 Hz, 2H), 7.20 (m, 4H), 6.76 (d, J = 7.8 
Hz, 2H), 6.71 (m, 2H), 5.03 (s, 4H), 4.27 (m, 4H), 3.57 (m, 18H), 3.47 (m, 
10H), 3.29 (s, 6H); 13C NMR (CDCl3): δ 168.47, 148.32, 141.00, 135.50, 125.61, 122.48, 121.92, 
O
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121.56, 119.14, 115.17, 113.46, 109.67, 107.87, 71.65, 70.31, 70.25, 70.23, 70.21, 70.19, 68.57, 
64.63, 58.75, 44.59; IR (NaCl, cm-1) : 3333, 1750; [α]D20 = - 45 (c = 0.5, CHCl3). 
 
 
 (S)-N-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethyl ester- 9H,9’H-[4,4’]Bicarbazole-3,3’-
O2PNMe2. To a solution of the diol (169 mg, 0.19 mmol) in MeCN  (2 
cm3), HMPT (37 µl, 0.19 mmol) was added and the resulting reaction 
mixture was refluxed at 70 ºC for 4 h. After this time the solvent was 
removed under reduced pressure to obtain a yellow oil (160 mg, 90%). 
Rf-value: 0.04 (PE:EtOAc, 0:1); 31P-NMR (CDCl3): δ 148.05; 1H NMR 
(CDCl3): δ 7.47 (d, J = 1.6 Hz, 2H),  7.40 (d, J = 8.7Hz, 1H), 7.33 (d, J 
= 8.7 Hz, 1H), 7.24 (m, 4H), 6.85 (d, J = 8.0 Hz, 1H), 6.76 (d, J = 8.0 
Hz, 1H), 6.51 (m, 2H), 5.14 (m, 4H), 4.34 (m, 4H), 3.63 (m, 4H), 3.54 
(m, 20H), 3.49 (m, 4H), 3.35 (d, J = 1.2 Hz, 12H), 2.55 (d, J = 9 Hz, 
6H); 13C NMR (CDCl3): δ 168.22 (d, J = 4 Hz), 144.81 (d, J = 12 Hz), 
140.97 (d, J = 5 Hz), 137.68, 137.13, 125.65, 122.56 (d, J = 13 Hz), 122.20, 122.42, 119.63, 
118.78 (d, J = 4 Hz), 108.80 (d, J = 10 Hz), 107.60 (d, J = 6 Hz), 71.72, 70.39, 70.32, 70.29, 
68.64, 68.61, 64.57, 64.48, 58.82, 44.60, 34.81 (d, J = 21 Hz); IR (NaCl, cm-1): 1751; [α]20D  = + 




Preparation of the catalyst:  
The Rh complex was prepared in situ by dissolving Rh(COD)2BF4 (33.7 mg, 0.083 mmol) and 
(S)-PEG-Phos (155 mg, 0.17 mmol) in CH2Cl2 (3.2 cm3) and after evaporation of the solvent 





General procedure hydrogenations: 
In a glass tube, 2 µmol of a preformed catalyst (0.81 mg (2 µmol) of Rh(COD)2BF4, 4 µmol of 
ligand in case of in situ formation), 200 µmol of the substrate and 4 cm3 of solvent, was added. 
This small glass tube was placed in a semi-automated autoclave with eight reactors (Endeavor) 
that was purged 4 times with  nitrogen and once with hydrogen. Then, the autoclave was 
pressurized with 10 bar of hydrogen. The reaction was stirred for 16 hours. A sample (1 cm3) of 
the resulting mixture was evaporated and dissolved in MeOH. To this solution was added 0.7 cm3 
of a 2 M (trimethylsilyl)diazomethane solution in ether. The yellow solution was filtered over a 
short silica plug and subjected to conversion (1H NMR) and e.e. determination (capillary GC). CP 
Chiralsil-L-Val from Chrompack (30m x 0.25mm x 0.12µm), 110 °C. Retention times: 3,4 
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